title: A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.
abstract: OBJECTIVE
  Glycogen storage disease type 3 (GSD III) is an autosomal recessive disorder caused by genetic mutations in the gene AGL. AGL encodes amylo-a-1, 6-glucosidase, 4-a-glucanotransferase, a glycogen debranching enzyme. GSD III is characterized by fasting hypoglycemia, hepatomegaly, growth retardation, progressive myopathy, and cardiomyopathy due to storage of abnormally structured glycogen in both skeletal and cardiac muscles and/or liver. The aim of this study is to detect mutations underlying GSD III in Saudi patients.
  
  
  METHODS
  A cross-sectional clinical genetic study of 5 Saudi consanguineous families examined at the metabolic clinic of the Madinah Maternity and Children Hospital.
  
  
  METHODS
  We present a biochemical and molecular analysis of 5 consanguineous Saudi families with GSD III. DNA was isolated from the peripheral blood of 31 individuals, including 12 patients, and the AGL gene was sequenced bidirectionally. DNA sequences were compared with the AGL reference sequence from the ensemble genome browser.
  
  
  RESULTS
  Genotyping and sequence analysis identified a homozygous intronic splice acceptor site mutation (IVS32-12A > G) in 4 families perfectly segregating with the phenotype. Complementary (c)DNA sequence analysis of the AGL gene revealed an 11-bp sequence insertion between exon 32 and exon 33 due to the creation of a new 3' splice site. The predicted mutant enzyme was truncated by 112 carboxyl-terminal amino acids as a result of premature termination.
  
  
  CONCLUSIONS
  Haplotype analysis revealed that the mutation arises as a result of founder effect, not an independent event. This is the first report of a genetic mutation in the AGL gene from Saudi Arabia. Screening for this mutation can improve genetic counseling and prenatal diagnosis of GSD III in Saudi Arabia.
authors.affiliation: Sulman Basit PhD, Center for Genetics and Inherited Diseases, Taibah University Al Madinah Al Munawarah, Saudi Arabia, T: +966-535370209, sbasit.phd@gmail.com.
authors.forename: Sulman
authors.initials: S
authors.lastname: Basit
authors.forename: Omhani
authors.initials: O
authors.lastname: Malibari
authors.affiliation: Sulman Basit PhD, Center for Genetics and Inherited Diseases, Taibah University Al Madinah Al Munawarah, Saudi Arabia, T: +966-535370209, sbasit.phd@gmail.com.
authors.forename: Alia Mahmood
authors.initials: AM
authors.lastname: Al Balwi
authors.forename: Firoz
authors.initials: F
authors.lastname: Abdusamad
authors.forename: Feras
authors.initials: F
authors.lastname: Abu Ismail
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003241:Consanguinity; D005091:Exons; D005260:Female; D018703:Founder Effect; D005820:Genetic Testing; D005838:Genotype; D006004:Glycogen Debranching Enzyme System / Q000235:genetics*; D006010:Glycogen Storage Disease Type III / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D022821:RNA Splice Sites; D012333:RNA, Messenger / Q000235:genetics*; D012529:Saudi Arabia; D055815:Young Adult
chemical_list: D006004:Glycogen Debranching Enzyme System; D022821:RNA Splice Sites; D012333:RNA, Messenger; C020569:4 alpha-glucanotransferase; C030563:amylo-1,6-glucosidase
references.citation: Hum Genet. 1998 Jan;102(1):1-5
references.pmid: 9490286
references.citation: JIMD Rep. 2013;7:19-26
references.pmid: 23430490
references.citation: J Hum Genet. 2014 Jan;59(1):42-5
references.pmid: 24257475
references.citation: Zhonghua Er Ke Za Zhi. 2013 Dec;51(12):915-9
references.pmid: 24495762
references.citation: Hum Genet. 2010 Aug;128(2):213-20
references.pmid: 20544222
references.citation: Mol Genet Metab. 2000 Jan;69(1):16-23
references.pmid: 10655153
references.citation: Hum Genet. 2000 Jan;106(1):108-15
references.pmid: 10982190
references.citation: Pediatr Endocrinol Rev. 2014 Mar;11(3):318-23
references.pmid: 24716397
references.citation: Am J Med Genet A. 2009 Feb 15;149A(4):662-5
references.pmid: 19283855
references.citation: Curr Mol Med. 2002 Mar;2(2):167-75
references.pmid: 11949933
references.citation: Eur J Hum Genet. 1997 Sep-Oct;5(5):266-70
references.pmid: 9412782
references.citation: J Hum Genet. 2012 Mar;57(3):170-5
references.pmid: 22089644
references.citation: Cases J. 2009 Jun 17;2:6891
references.pmid: 19829878
references.citation: J Clin Invest. 1996 Jul 15;98(2):352-7
references.pmid: 8755644
references.citation: Ann Biol Clin (Paris). 2012 Nov-Dec;70(6):648-50
references.pmid: 23207808
references.citation: Mol Genet Metab. 2014 Apr;111(4):467-76
references.pmid: 24613482
references.citation: Eur J Biochem. 1967 Oct;2(3):265-70
references.pmid: 5235982
references.citation: Hum Mutat. 2006 Jun;27(6):600-1
references.pmid: 16705713